北京大学学报(医学版) ›› 2015, Vol. 47 ›› Issue (1): 27-31.

• 论著 • 上一篇    下一篇

不同时机口服抗菌药物辅助机械治疗重度慢性牙周炎的临床疗效

李熠,徐莉△,路瑞芳,安悦邦,王宪娥,宋文莉,孟焕新   

  1. (北京大学口腔医学院·口腔医院牙周科,北京100081)
  • 出版日期:2015-02-18 发布日期:2015-02-18

Clinical effect of different sequences of debridement-antibiotic therapy in treatment of severe chronic periodontitis

LI Yi, XU Li△, LU Rui-fang, AN Yue-bang, WANG Xian-e, SONG Wen-li, MENG Huan-xin   

  1. (Department of Periodontology, Peking University School and Hospital of Stomatology, Beijing 100081, China)
  • Online:2015-02-18 Published:2015-02-18

摘要: 目的:评价重度慢性牙周炎(chronic periodontitis, CP)患者1周内完成全口龈下刮治及根面平整的可行性及治疗过程中不同时机口服阿莫西林和甲硝唑的临床疗效。方法: 选取30例重度慢性牙周炎患者,男性14例,女性16例,平均年龄40.5±8.4岁(35~60岁),按照随机数字表分为A组(刮治同期用药),B组(刮治后用药)和C组(单纯刮治),每组10例。所有患者均于1周内分2次完成全口牙周机械治疗(刮治和根面平整)。A组在龈下刮治开始前0.5~1 h服用阿莫西林胶囊(0.5 g,3次/d)+甲硝唑片(0.2 g,3次/d),连服7 d; B组在全口龈下刮治完成次日开始服用阿莫西林胶囊(0.5 g,3次/d)+甲硝唑片(0.2 g,3次/d),连服7 d; C组服用安慰剂。3组均在牙周治疗前及治疗完成后2个月进行全口牙周临床检查,观察指标包括菌斑指数、探诊深度(probing depth, PD)、出血指数(bleeding index, BI)和牙齿松动度等。计算全口牙位点的平均探诊深度、平均邻面探诊深度(proximal probing depth, pPD),PD>5 mm位点的百分比(PD>5 mm%)、邻面PD>5 mm位点的百分比(pPD>5 mm%)、平均BI及探诊出血比率(percentage of sites with bleeding on probing,BOP%)。结果:(1)治疗前后PD、pPD、PD>5 mm%和pPD>5 mm%有显著降低(P<0.001);BOP%也有显著降低(P<0.05)。 (2) A组平均PD减少值[(2.15±0.42) mm]显著优于B组[(1.76±0.29) mm]和C组[(1.57±0.33) mm], P<0.05。B组[(1.76±0.29)mm]与C组[(1.57±0.33) mm]平均PD减少值差异无统计学意义,P=0.354。A组pPD减少值[(2.45±0.43) mm]显著优于单纯刮治组[(1.90±0.48)mm], P<0.05。A组、B组与C组组间BI及BOP%的改善程度差异无统计学意义。结论:重度慢性牙周炎患者1周内分两次完成全口龈下刮治是安全可行的,龈下刮治同时口服阿莫西林胶囊+甲硝唑较龈下刮治后用药和单纯刮治探诊深度减少更显著。

关键词: 牙周炎, 牙科刮治术, 阿莫西林, 甲硝唑

Abstract: Objective: To evaluate the feasibility of full-mouth debridement (subgingival scaling and root planning, SRP) by 2 times within 1 week and compare the clinical effects of different sequences of debridement-antibiotic usage in patients with severe chronic periodontitis (CP). Methods: A doubleblinded, placebo-controlled, randomized clinical trial was conducted in 30 severe CP patients (14 males and 16 females, 40.5±8.4 years old on average from 35 to 60) receiving 3 different sequences of debridement-antibiotictherapy: Group A, antibiotic usage (metronidazole, MTZ, 0.2 g, tid, 7 d; amoxicillin, AMX 0.5 g, tid, 7 d) was started together with SRP (completed by 2 times in 7 d); Group B, antibiotic usage (MTZ 0.2 g, tid, 7 d; AMX 0.5 g, tid, 7 d) was started 1 d after SRP(completed by 2 times in 7 d); Group C, SRP alone[probing depth (PD), bleeding index (BI) and tooth mobility] was examined. The average full-mouth probing depth, the average fullmouth proximal probing depth (pPD), the percentage of sites with PD>5 mm (PD>5 mm%), the percentage of sites with proximal PD>5 mm (pPD>5 mm%), the average bleeding index (BI) and the percentage of sites with bleeding on probing (BOP%) were calculated. Clinical examinations were performed at baseline and 2 months post therapy. Results: (1) Compared with baseline conditions, all the subjects showed clinical improvements in all the parameters evaluated 2 months post therapy, P<0.05. (2) Significant difference were observed in the average PD changes between Group A [(2.15±0.42) mm], Group B [(1.76±0.29) mm] and Group C [(1.57±0.33) mm], P<0.05. No significant difference was observed in the average PD changes between Group B and Group C, P=0.354. Significant differences were observed in the average pPD changes between Group A [(2.45±0.43)mm] and Group C[(1.90±0.48) mm], P<0.05. No significant difference was observed in BI and BOP% changes between Group A,Group B and Group C. Conclusion: For patients with severe chronic periodontitis, it is safe and feasible to receive full-mouth SRP by 2 times within 1 week. The shortterm (2 months) advantages in PD changes are observed in patients receiving SRP and antibiotic usage at the same time comparing with patients using antibiotics after SRP or SRP alone.

Key words: Periodontitis, Dental scaling, Amoxicillin, Metronidazole

[1] 朱小玲,李文静,王宪娥,宋文莉,徐莉,张立,冯向辉,路瑞芳,释栋,孟焕新. 细胞色素B-245α链及胆固醇酯转运蛋白基因多态性与广泛型侵袭性牙周炎易感性的关系[J]. 北京大学学报(医学版), 2022, 54(1): 18-22.
[2] 徐欣然,霍芃呈,和璐,孟焕新,朱筠轩,靳东思奇. 伴与不伴糖尿病的牙周炎患者牙周基础治疗的疗效比较及其与白细胞水平的相关分析[J]. 北京大学学报(医学版), 2022, 54(1): 48-53.
[3] 郜洪宇,孟焕新,侯建霞,黄宝鑫,李玮. 钙结合蛋白在健康牙周组织和实验性牙周炎组织的表达分布[J]. 北京大学学报(医学版), 2021, 53(4): 744-749.
[4] 刘建,王宪娥,吕达,乔敏,张立,孟焕新,徐莉,毛铭馨. 广泛型侵袭性牙周炎患者牙根形态异常与相关致病基因的关联[J]. 北京大学学报(医学版), 2021, 53(1): 16-23.
[5] 郜洪宇,徐菁玲,孟焕新,和璐,侯建霞. 牙周基础治疗对2型糖尿病伴慢性牙周炎患者红细胞、血小板相关指标的影响[J]. 北京大学学报(医学版), 2020, 52(4): 750-754.
[6] 闫乐,王宪娥,詹雅琳,苗莉莉,韩烨,张楚人,岳兆国,胡文杰,侯建霞. 超声龈下清创联合手工根面平整术治疗重度牙周炎的临床效果[J]. 北京大学学报(医学版), 2020, 52(1): 64-70.
[7] 张勇,刘畅,陈彬,陈帆,段晋瑜,张孟钧,焦剑. 糖尿病前期患者糖代谢异常与慢性牙周炎的相关性[J]. 北京大学学报(医学版), 2020, 52(1): 71-76.
[8] 朱洁,李建红,袁婷婷,和璐,梁宇红. 绝经期妇女牙周状况与骨质密度的相关性分析[J]. 北京大学学报(医学版), 2019, 51(6): 1115-1118.
[9] 石姝雯,孟洋,焦剑,李文静,孟焕新,栾庆先,王万春. 根分叉病变患牙经牙周非手术治疗后5年失牙状况及多因素分析[J]. 北京大学学报(医学版), 2019, 51(5): 913-918.
[10] 杜仁杰,焦剑,周彦恒,施捷. 侵袭性牙周炎患者正畸前后的咬合变化[J]. 北京大学学报(医学版), 2019, 51(5): 919-924.
[11] 刘园,栾庆先. 北京石景山社区中老年人群慢性牙周炎和颈动脉内膜中层厚度的相关性[J]. 北京大学学报(医学版), 2018, 50(2): 264-270.
[12] 张海东,张立,释栋,韩劼,闫夏,谢也斯,孟焕新. 锥形锁柱种植体用于因牙周炎缺牙患者修复的临床观察[J]. 北京大学学报(医学版), 2018, 50(2): 300-307.
[13] 张又文,辛天艺,焦剑,周彦恒,施捷. 慢性牙周炎的减数正畸治疗[J]. 北京大学学报(医学版), 2018, 50(2): 308-313.
[14] 李熠,徐莉,周彦恒,欧阳翔英,曹甜. 牙周正畸牙体联合治疗1例预后无望上前牙患者的长期疗效观察#br#[J]. 北京大学学报(医学版), 2017, 49(4): 740-744.
[15] 高丽,于晓潜,蔡宇. 丝线结扎及局部涂抹牙龈卟啉单胞菌对小鼠牙槽骨骨吸收的影响[J]. 北京大学学报(医学版), 2017, 49(1): 31-035.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 田增民, 陈涛, Nanbert ZHONG, 李志超, 尹丰, 刘爽. 神经干细胞移植治疗遗传性小脑萎缩的临床研究(英文稿)[J]. 北京大学学报(医学版), 2009, 41(4): 456 -458 .
[2] 成刚, 钱振华, 胡军. 艾滋病项目自愿咨询检测的技术效率分析[J]. 北京大学学报(医学版), 2009, 41(2): 135 -140 .
[3] 卢恬, 朱晓辉, 柳世庆, 郑杰, 邱晓彦. 白细胞介素2促进宫颈癌细胞系HeLaS3免疫球蛋白G的表达[J]. 北京大学学报(医学版), 2009, 41(2): 158 -161 .
[4] 徐莉, 孟焕新, 张立, 陈智滨, 冯向辉, 释栋. 侵袭性牙周炎患者血清中抗牙龈卟啉单胞菌的IgG抗体水平的研究[J]. 北京大学学报(医学版), 2009, 41(1): 52 -55 .
[5] 祁琨, 邓芙蓉, 郭新彪. 纳米二氧化钛颗粒对人肺成纤维细胞缝隙连接通讯的影响[J]. 北京大学学报(医学版), 2009, 41(3): 297 -301 .
[6] 丰雷, 王玉凤, 曹庆久. 哌甲酯对注意缺陷多动障碍儿童平衡功能影响的开放性研究[J]. 北京大学学报(医学版), 2007, 39(3): 304 -309 .
[7] 刘津, 王玉凤. 父母培训对共患对立违抗性障碍的注意缺陷多动障碍的作用[J]. 北京大学学报(医学版), 2007, 39(3): 310 -314 .
[8] 钱秋谨, 杨莉, 王玉凤. 儿童注意缺陷多动障碍的研究进展[J]. 北京大学学报(医学版), 2007, 39(3): 323 -328 .
[9] . 消息[J]. 北京大学学报(医学版), 2007, 39(3): 12 .
[10] 马明信. 重视并提高疑难/罕见淋巴瘤的诊治[J]. 北京大学学报(医学版), 2007, 39(4): 342 .